Objective: To investigate the distribution of the popula- tion with iow level HBsAg in serum and the characteri- stics of their HBV serologic markers. Methods: We detected HBsAg, HBeAg, anti-HBc, an- ti-HBe, and anti-...Objective: To investigate the distribution of the popula- tion with iow level HBsAg in serum and the characteri- stics of their HBV serologic markers. Methods: We detected HBsAg, HBeAg, anti-HBc, an- ti-HBe, and anti-HBs in the serum samples from 8089 non-hepatitis inpatients and defined the patients with HBsAg concentration equal to or less than 5 μg/L by using the AxSYM microparticle enzyme immunoassay (MEIA) system. Results: 189 patients with HBsAg equal to or Iow than 5 μg/L (2.34% of all 8089 patients and 23.16% of 816 HBsAg positive patients) included 84 (44.40%), 33 (17.5%) and 72 (38.10%) with HBsAg equal to or less than 1 μg/L, 1-2 μg/L and 2-5 μg/L respec- tively. Most of these patients were detected with 'posi- tive for HBsAg, anti-HBc and anti-HBe but negative for HBeAg and anti-HBs', and anti-HBc antibodies were frequently present in their sera. Conclusions: The population with low Level HBsAg in serum should not be neglected and it is important to improve the test sensitivity of HBsAg and to detect the other HBV serologic markers.展开更多
Thirty-six cases originally diagnosed histologically as malignant lymphoma (ML) or anaplastic carcinoma were reexamined immunohistochemically by leukocyte common antigen (LCA) and epithelial membrane antigen (EMA). 5/...Thirty-six cases originally diagnosed histologically as malignant lymphoma (ML) or anaplastic carcinoma were reexamined immunohistochemically by leukocyte common antigen (LCA) and epithelial membrane antigen (EMA). 5/18 cases originally diagnosed as ' anaplastic carcinoma'' and 'anaplastic carcinoma? (ML to be excluded)' , showed positive staining for LCA and negative for EMA; whereas 3 cases originally diagnosed as malignancy unclassified turned out to be ML, with the relevant assay performed.展开更多
文摘Objective: To investigate the distribution of the popula- tion with iow level HBsAg in serum and the characteri- stics of their HBV serologic markers. Methods: We detected HBsAg, HBeAg, anti-HBc, an- ti-HBe, and anti-HBs in the serum samples from 8089 non-hepatitis inpatients and defined the patients with HBsAg concentration equal to or less than 5 μg/L by using the AxSYM microparticle enzyme immunoassay (MEIA) system. Results: 189 patients with HBsAg equal to or Iow than 5 μg/L (2.34% of all 8089 patients and 23.16% of 816 HBsAg positive patients) included 84 (44.40%), 33 (17.5%) and 72 (38.10%) with HBsAg equal to or less than 1 μg/L, 1-2 μg/L and 2-5 μg/L respec- tively. Most of these patients were detected with 'posi- tive for HBsAg, anti-HBc and anti-HBe but negative for HBeAg and anti-HBs', and anti-HBc antibodies were frequently present in their sera. Conclusions: The population with low Level HBsAg in serum should not be neglected and it is important to improve the test sensitivity of HBsAg and to detect the other HBV serologic markers.
文摘Thirty-six cases originally diagnosed histologically as malignant lymphoma (ML) or anaplastic carcinoma were reexamined immunohistochemically by leukocyte common antigen (LCA) and epithelial membrane antigen (EMA). 5/18 cases originally diagnosed as ' anaplastic carcinoma'' and 'anaplastic carcinoma? (ML to be excluded)' , showed positive staining for LCA and negative for EMA; whereas 3 cases originally diagnosed as malignancy unclassified turned out to be ML, with the relevant assay performed.
